在急性髓性白血病研究中,对无事件生存率与治愈率的统计考虑
Yuichiro Kaneko1, Kentaro Takeda1, Shufang Liu2
1Clinical Operations, Quantitative Sciences and China Development, Astellas Pharma Global Development Inc., Northbrook, Illinois, USA.
Pharmaceutical statistics
|November 17, 2025
概括
这项研究引入了针对急性髓性白血病 (AML) 试验的新样本大小计算方法. 它解释了治疗失败和潜在的治愈,提高了无事件生存 (EFS) 终点的准确性.
科学领域:
- 血液学 血液学 血液学
- 临床试验 临床试验
- 生物统计学 生物统计学
背景情况:
- 无事件生存率 (EFS) 是急性髓性白血病 (AML) 研究的主要终点.
- 诱导治疗失败 (ITF) 被定义为没有实现完全缓解 (CR).
- 最近的FDA指南 (2022) 指定ITF作为随机事件,承认可变的诱导周期.
研究的目的:
- 为了解决AML试验传统样本大小计算的局限性.
- 开发一种新的样本大小计算方法,同时考虑ITF和治愈分数.
- 根据现有的方法和模拟数据验证拟议的方法.
主要方法:
- 将日志级别测试统计数据分解为ITF和非ITF组件,类似于Xu等. (2021年). 在2021年.
- 开发一种新的样本大小计算公式,将ITF和治愈分数纳入其中.
- 分析计算功率与来自各种样本设置模拟的实证功率的比较.
主要成果:
- 拟议的样本大小计算方法表明分析能力与模拟中的经验能力密切匹配.
- 新方法有效地解释了诱导治疗失败和治愈患者的存在.
- 该方法有助于防止在AML研究中高估或低估治疗分数所需的样本大小.
结论:
- 开发的样本大小计算方法为AML临床试验提供了更准确的方法.
- 计算ITF和治疗分数对于强大的统计能力和适当的样本大小确定至关重要.
- 这种方法提高了EFS作为AML研究的终点的可靠性.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
30.3K
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
592
相关概念视频
01:21Cancer Survival Analysis
624
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
624
01:15Assumptions of Survival Analysis
375
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
375
01:20Comparing the Survival Analysis of Two or More Groups
525
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
525
01:20Actuarial Approach
274
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
274
01:24Kaplan-Meier Approach
526
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
526
01:18Introduction To Survival Analysis
701
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
701